Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Analyst ; 148(11): 2594-2608, 2023 May 30.
Article in English | MEDLINE | ID: mdl-37166147

ABSTRACT

Radiation therapy is currently utilised in the treatment of approximately 50% of cancer patients. A move towards patient tailored radiation therapy would help to improve the treatment outcome for patients as the inter-patient and intra-patient heterogeneity of cancer leads to large differences in treatment responses. In radiation therapy, a typical treatment outcome is cell cycle arrest which leads to cell cycle synchronisation. As treatment is typically given over multiple fractions it is important to understand how variation in the cell cycle can affect treatment response. Raman spectroscopy has previously been assessed as a method for monitoring radiation response in cancer cells and has shown promise in detecting the subtle biochemical changes following radiation exposure. This study evaluated Raman spectroscopy as a potential tool for monitoring cellular response to radiation in synchronised versus unsynchronised UVW human glioma cells in vitro. Specifically, it was hypothesised that the UVW cells would demonstrate a greater radiation resistance if the cell cycle phase of the cells was synchronised to the G1/S boundary prior to radiation exposure. Here we evaluated whether Raman spectroscopy, combined with cell cycle analysis and DNA damage and repair analysis (γ-H2AX assay), could discriminate the subtle cellular changes associated with radiation response. Raman spectroscopy combined with principal component analysis (PCA) was able to show the changes in radiation response over 24 hours following radiation exposure. Spectral changes were assigned to variations in protein, specifically changes in protein signals from amides as well as changes in lipid expression. A different response was observed between cells synchronised in the cell cycle and unsynchronised cells. After 24 hours following irradiation, the unsynchronised cells showed greater spectral changes compared to the synchronised cells demonstrating that the cell cycle plays an important role in the radiation resistance or sensitivity of the UVW cells, and that radiation resistance could be induced by controlling the cell cycle. One of the main aims of cancer treatment is to stop the proliferation of cells by controlling or halting progression through the cell cycle, thereby highlighting the importance of controlling the cell cycle when studying the effects of cancer treatments such as radiation therapy. Raman spectroscopy has been shown to be a useful tool for evaluating the changes in radiation response when the cell cycle phase is controlled and therefore highlighting its potential for assessing radiation response and resistance.


Subject(s)
Brain Neoplasms , Spectrum Analysis, Raman , Humans , Spectrum Analysis, Raman/methods , Cell Cycle/radiation effects , Cell Line, Tumor , Brain Neoplasms/radiotherapy
2.
J Perianesth Nurs ; 35(1): 29-33, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31648873

ABSTRACT

PURPOSE: The purpose of this study was to identify the incidence and severity of catheter-related bladder discomfort (CRBD) among nonurological adult patients in a postanesthesia care unit with catheter sizes of 10 to 18 Fr. DESIGN: Descriptive, prospective, and quantitative study. METHODS: In all, 401 patients were included. Incidence and severity of CRBD were assessed upon arrival and 1 hour after arrival. FINDINGS: CRBD incidence was 17.2% (n = 69) on arrival versus 19.1 (n = 74) 1 hour after arrival. Male gender showed a significantly higher risk of developing CRBD upon arrival (odds ratio, 3.15; P = .000; 95% confidence interval, 1.78 to 5.59), and 1 hour after arrival (odds ratio, 2.34; P = .002; 95% confidence interval, 1.38 to 3.99). CONCLUSIONS: The findings suggest using a catheter as small as possible and confirm that men experience significantly more discomfort, whatever sized catheter is used.


Subject(s)
Urinary Bladder/abnormalities , Urinary Catheters/adverse effects , Adult , Female , Humans , Incidence , Male , Middle Aged , Postanesthesia Nursing/methods , Postoperative Care/methods , Prospective Studies , Urinary Bladder/injuries
3.
AMB Express ; 7(1): 18, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28058634

ABSTRACT

In this study we describe the heterologous expression of the recently identified cyanobacterial pathway for long chain alkane biosynthesis, involving the reduction of fatty acyl-ACP to fatty aldehyde and the subsequent conversion of this into alkanes, in the filamentous fungus Aspergillus carbonarius ITEM 5010. Genes originating from Synechococcus elongatus strain PCC7942, encoding acyl-ACP/CoA reductase and aldehyde deformylating oxygenase enzymes, were successfully expressed in A. carbonarius, which lead to the production of pentadecane and heptadecane, alkanes that have not been previously produced by this fungus. Titers of 0.2, 0.5 and 2.7 mg/l pentadecane and 0.8, 1.6 and 10.2 mg/l heptadecane were achieved using glucose, Yeast malt and oatmeal media, respectively. Besides producing alkanes, we found elevated levels of internal free fatty acids and triglycerides in the alkane producing transformant. These findings can indicate that a yet unidentified, native fatty aldehyde dehydrogenase channels back the fatty aldehydes into the fatty acid metabolism, thus competing for substrate with the heterologously expressed fatty aldehyde deformylating oxygenase. These findings will potentially facilitate the future application of robust, fungal cell factories for the production of advanced biofuels from various substrates.

4.
Disabil Rehabil ; 38(12): 1216-26, 2016.
Article in English | MEDLINE | ID: mdl-26289371

ABSTRACT

PURPOSE: In order to enhance the quality of the data collected in a multicentre validation study of a revised Danish version of the McGill Ingestive Skills Assessment (MISA), the authors developed a rater training programme. The purpose of the present study was to evaluate the effect of the training on scoring performance and scale-specific expertise amongst raters. METHOD: During 2 days of rater training, 81 occupational therapists (OTs) were qualified to observe and score dysphagic clients' mealtime performance according to the criteria of 36 MISA-items. The training effects were evaluated pre- to post-training using percentage exact agreement (PA) of scored MISA items of a case-vignette and a Likert scale self-report of scale-specific expertise. RESULTS: PA increased significantly from pre- to post-training (Z = -4.404, p < 0.001), although items for which the case-vignette reflected deficient mealtime performance appeared most difficult to score. The OTs scale-specific expertise improved significantly (knowledge: Z = -7.857, p < 0.001 and confidence: Z = -7.838, p < 0.001). CONCLUSION: Rater training improved OTs scoring performance when using the Danish MISA as well as their perceived scale-specific expertise. Future rater training should emphasis the items identified as those most difficult to score. Additionally, further studies addressing different training approaches and durations are warranted. IMPLICATIONS FOR REHABILITATION: When occupational therapists (OTs) use the McGill Ingestive Skills Assessment (MISA) they observe, interpret and record occupational performance of dysphagic clients participating in a meal. This is a highly complex task, which might introduce unwanted variability in measurement scores. A 2-day rater training programme was developed and this builds on the findings of several studies. These suggest that combinations of different training methods tend to yield the most effective results. Participation in the newly developed training programme on how to administer the MISA significantly reduces unwanted variability in measurement scores and improves OTs' competency. The training programme could be used in undergraduate and postgraduate dysphagia education initiatives to help OTs understanding of the content and the scoring criteria for each aspect of occupational performance during a meal, thus developing observation skills as well as recognizing and avoiding the most common errors in measurement scores.


Subject(s)
Deglutition Disorders/diagnosis , Geriatric Assessment/methods , Occupational Therapists/education , Psychometrics/methods , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Denmark , Female , Humans , Language , Male , Middle Aged , Reproducibility of Results , Surveys and Questionnaires
5.
Analyst ; 141(1): 100-10, 2016 Jan 07.
Article in English | MEDLINE | ID: mdl-26456100

ABSTRACT

A major limitation with current in vitro technologies for testing anti-cancer therapies at the pre-clinical level is the use of 2D cell culture models which provide a poor reflection of the tumour physiology in vivo. Three dimensional cell culture models, such as the multicellular spheroid, provide instead a more accurate representation. However, existing spheroid-based assessment methods are generally labour-intensive and low-throughput. Emulsion based technologies offer enhanced mechanical stability during multicellular tumour spheroid formation and culture and are scalable to enable higher-throughput assays. The aim of this study was to investigate the characteristics of emulsion-based techniques for the formation and long term culture of multicellular UVW glioma cancer spheroids and apply these findings to assess the cytotoxic effect of radiation on spheroids. Our results showed that spheroids formed within emulsions had similar morphological and growth characteristics to those formed using traditional methods. Furthermore, we have identified the effects produced on the proliferative state of the spheroids due to the compartmentalised nature of the emulsions and applied this for mimicking tumour growth and tumour quiescence. Finally, proof of concept results are shown to demonstrate the scalability potential of the technology for developing high-throughput screening assays.


Subject(s)
Cell Culture Techniques/methods , Spheroids, Cellular/pathology , Spheroids, Cellular/radiation effects , Cell Culture Techniques/instrumentation , Cell Line, Tumor , Cell Proliferation , Emulsions , Humans , Lab-On-A-Chip Devices
6.
Fungal Biol ; 119(4): 274-82, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25813514

ABSTRACT

The filamentous fungus, Asperigillus carbonarius, is able to produce a series of hydrocarbons in liquid culture using lignocellulosic biomasses, such as corn stover and switch grass as carbon source. The hydrocarbons produced by the fungus show similarity to jet fuel composition and might have industrial application. The production of hydrocarbons was found to be dependent on type of media used. Therefore, ten different carbon sources (oat meal, wheat bran, glucose, carboxymethyl cellulose, avicel, xylan, corn stover, switch grass, pretreated corn stover, and pretreated switch grass) were tested to identify the maximum number and quantity of hydrocarbons produced. Several hydrocarbons were produced include undecane, dodecane, tetradecane, hexadecane 2,4-dimethylhexane, 4-methylheptane, 3-methyl-1-butanol, ethyl benzene, o-xylene. Oatmeal was found to be the carbon source resulting in the largest amounts of hydrocarbon products. The production of fungal hydrocarbons, especially from lignocellulosic biomasses, holds a great potential for future biofuel production whenever our knowledge on regulators and pathways increases.


Subject(s)
Aspergillus/metabolism , Biofuels/microbiology , Hydrocarbons/metabolism , Culture Media/chemistry , Lignin/metabolism
7.
Cell Tissue Res ; 352(3): 695-705, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23644740

ABSTRACT

SEPTIN9 (SEPT9) is a filament-forming protein involved in numerous cellular processes. We have used a conditional knock out allele of Sept9 to specifically delete Sept9 in T-cells. As shown by fluorescence-activated cell sorting, loss of Sept9 at an early thymocyte stage in the thymus results in increased numbers of double-negative cells indicating that SEPT9 is involved in the transition from the double-negative stage during T-cell development. Accordingly, the relative numbers of mature T-cells in the periphery are decreased in mice with a T-cell-specific deletion of Sept9. Proliferation of Sept9-deleted CD8(+) T-cells from the spleen is decreased upon stimulation in culture. The altered T-cell homeostasis caused by the loss of Sept9 results in an increase of CD8(+) central memory T-cells.


Subject(s)
CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/metabolism , Homeostasis/immunology , Septins/metabolism , Animals , Cell Count , Cell Differentiation/genetics , Cell Proliferation , Down-Regulation/genetics , Immunologic Memory/genetics , Integrases/metabolism , Lymphocyte Depletion , Lymphoid Tissue/cytology , Lymphoid Tissue/metabolism , Mice , Mice, Knockout , Real-Time Polymerase Chain Reaction , Septins/genetics , Up-Regulation/genetics
8.
J Nucl Med ; 54(6): 953-60, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23616582

ABSTRACT

UNLABELLED: Disulfiram has been used for several decades in the treatment of alcoholism. It now shows promise as an anticancer drug and radiosensitizer. Proposed mechanisms of action include the induction of oxidative stress and inhibition of proteasome activity. Our purpose was to determine the potential of disulfiram to enhance the antitumor efficacy of external-beam γ-irradiation and (131)I-metaiodobenzylguanidine ((131)I-MIBG), a radiopharmaceutical used for the therapy of neuroendocrine tumors. METHODS: The role of copper in disulfiram-induced toxicity was investigated by clonogenic assay after treatment of human SK-N-BE(2c) neuroblastoma and UVW/noradrenaline transporter (NAT) glioma cells. The synergistic interaction between disulfiram and radiotherapy was evaluated by combination-index analysis. Tumor growth delay was determined in vitro using multicellular tumor spheroids and in vivo using human tumor xenografts in athymic mice. RESULTS: Escalating the disulfiram dosage caused a biphasic reduction in the surviving fraction of clonogens. Clonogenic cell kill after treatment with disulfiram concentrations less than 4 µM was copper-dependent, whereas cytotoxicity at concentrations greater than 10 µM was caused by oxidative stress. The cytotoxic effect of disulfiram was maximal when administered with equimolar copper. Likewise, disulfiram radiosensitization of tumor cells was copper-dependent. Furthermore, disulfiram treatment enhanced the toxicity of (131)I-MIBG to spheroids and xenografts expressing the noradrenaline transporter. CONCLUSION: The results demonstrate that the cytotoxicity of disulfiram was copper-dependent, the molar excess of disulfiram relative to copper resulted in attenuation of disulfiram-mediated cytotoxicity, copper was required for the radiosensitizing activity of disulfiram, and copper-complexed disulfiram enhanced the efficacy not only of external-beam radiation but also of targeted radionuclide therapy in the form of (131)I-MIBG. Therefore, disulfiram may have anticancer potential in combination with radiotherapy.


Subject(s)
Antineoplastic Agents/pharmacology , Copper/metabolism , Disulfiram/pharmacology , Radiation Tolerance/drug effects , 3-Iodobenzylguanidine/therapeutic use , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Proliferation/radiation effects , Cell Transformation, Neoplastic , Dose-Response Relationship, Drug , Female , Gamma Rays/therapeutic use , Humans , Mice , Spheroids, Cellular/drug effects , Spheroids, Cellular/pathology , Spheroids, Cellular/radiation effects
9.
Radiat Res ; 179(3): 282-92, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23336184

ABSTRACT

The use of radiation-inducible promoters to drive transgene expression offers the possibility of temporal and spatial regulation of gene activation. This study assessed the potential of one such promoter element, p21(WAF1/CIP1) (WAF1), to drive expression of the noradrenaline transporter (NAT) gene, which conveys sensitivity to radioiodinated meta-iodobenzylguanidine (MIBG). An expression vector containing NAT under the control of the radiation-inducible WAF1 promoter (pWAF/NAT) was produced. The non-NAT expressing cell lines UVW (glioma) and HCT116 (colorectal cancer) were transfected with this construct to assess radiation-controlled WAF1 activation of the NAT gene. Transfection of UVW and HCT cells with pWAF/NAT conferred upon them the ability to accumulate [(131)I]MIBG, which led to increased sensitivity to the radiopharmaceutical. Pretreatment of transfected cells with γ radiation or the radiopharmaceuticals [(123)I]MIBG or [(131)I]MIBG induced dose- and time-dependent increases in subsequent [(131)I]MIBG uptake and led to enhanced efficacy of [(131)I]MIBG-mediated cell kill. Gene therapy using WAF1-driven expression of NAT has the potential to expand the use of this therapeutic modality to tumors that lack a radio-targetable feature.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p21/genetics , Gamma Rays , Norepinephrine Plasma Membrane Transport Proteins/genetics , Promoter Regions, Genetic , Transgenes , Cell Line, Tumor , Humans , Real-Time Polymerase Chain Reaction
10.
Biomolecules ; 3(3): 612-31, 2013 Sep 03.
Article in English | MEDLINE | ID: mdl-24970184

ABSTRACT

Profitable biomass conversion processes are highly dependent on the use of efficient enzymes for lignocellulose degradation. Among the cellulose degrading enzymes, beta-glucosidases are essential for efficient hydrolysis of cellulosic biomass as they relieve the inhibition of the cellobiohydrolases and endoglucanases by reducing cellobiose accumulation. In this review, we discuss the important role beta-glucosidases play in complex biomass hydrolysis and how they create a bottleneck in industrial use of lignocellulosic materials. An efficient beta-glucosidase facilitates hydrolysis at specified process conditions, and key points to consider in this respect are hydrolysis rate, inhibitors, and stability. Product inhibition impairing yields, thermal inactivation of enzymes, and the high cost of enzyme production are the main obstacles to commercial cellulose hydrolysis. Therefore, this sets the stage in the search for better alternatives to the currently available enzyme preparations either by improving known or screening for new beta-glucosidases.

11.
Can J Microbiol ; 58(9): 1035-46, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22906186

ABSTRACT

The newly discovered fungal species Aspergillus saccharolyticus was found to produce a culture broth rich in ß-glucosidase activity. In this present work, the main ß-glucosidase of A. saccharolyticus responsible for the efficient hydrolytic activity was identified, isolated, and characterized. Ion exchange chromatography was used to fractionate the culture broth, yielding fractions with high ß-glucosidase activity and only 1 visible band on an SDS-PAGE gel. Mass spectrometry analysis of this band gave peptide matches to ß-glucosidases from aspergilli. Through a polymerase chain reaction approach using degenerate primers and genome walking, a 2919 bp sequence encoding the 860 amino acid BGL1 polypeptide was determined. BGL1 of A. saccharolyticus has 91% and 82% identity with BGL1 from Aspergillus aculeatus and BGL1 from Aspergillus niger , respectively, both belonging to Glycoside Hydrolase family 3. Homology modeling studies suggested ß-glucosidase activity with preserved retaining mechanism and a wider catalytic pocket compared with other ß-glucosidases. The bgl1 gene was heterologously expressed in Trichoderma reesei QM6a, purified, and characterized by enzyme kinetics studies. The enzyme can hydrolyze cellobiose, p-nitrophenyl-ß-d-glucoside, and cellodextrins. The enzyme showed good thermostability, was stable at 50 °C, and at 60 °C it had a half-life of approximately 6 h.


Subject(s)
Aspergillus/enzymology , Models, Molecular , beta-Glucosidase/chemistry , beta-Glucosidase/metabolism , Amino Acid Sequence , Aspergillus/genetics , Cellobiose/metabolism , Cellulose/analogs & derivatives , Cellulose/metabolism , Dextrins/metabolism , Half-Life , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Molecular Sequence Data , Protein Structure, Tertiary , Sequence Alignment , Temperature , Trichoderma/genetics , beta-Glucosidase/genetics
12.
J Nucl Med ; 53(4): 647-54, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22414636

ABSTRACT

UNLABELLED: Oncolytic herpes viruses show promise for cancer treatment. However, it is unlikely that they will fulfill their therapeutic potential when used as monotherapies. An alternative strategy is to use these viruses not only as oncolytic agents but also as a delivery mechanism of therapeutic transgenes to enhance tumor cell killing. The herpes simplex virus 1 deletion mutant HSV1716 is a conditionally replicating oncolytic virus that selectively replicates in and lyses dividing tumor cells. It has a proven safety profile in clinical trials and has demonstrated efficacy as a gene-delivery vehicle. To enhance its therapeutic potential, we have engineered HSV1716 to convey the noradrenaline transporter (NAT) gene (HSV1716/NAT), whose expression endows infected cells with the capacity to accumulate the noradrenaline analog metaiodobenzylguanidine (MIBG). Thus, the NAT gene-infected cells are susceptible to targeted radiotherapy using radiolabeled (131)I-MIBG, a strategy that has already shown promise for combined targeted radiotherapy-gene therapy in cancer cells after plasmid-mediated transfection. METHODS: We used HSV1716/NAT as a dual cell lysis-gene delivery vehicle for targeting the NAT transgene to human tumor xenografts in vivo. RESULTS: In tumor xenografts that did not express NAT, intratumoral or intravenous injection of HSV1716/NAT induced the capacity for active uptake of (131)I-MIBG. Administration of HSV1716/NAT and (131)I-MIBG resulted in decreased tumor growth and enhanced survival relative to injection of either agent alone. Efficacy was dependent on the scheduling of delivery of the 2 agents. CONCLUSION: These findings support a role for combination radiotherapy-gene therapy for cancer using HSV1716 expressing the NAT transgene and targeted radionuclide therapy.


Subject(s)
Gene Transfer Techniques , Glioma/genetics , Glioma/radiotherapy , Herpesvirus 1, Human/genetics , Molecular Targeted Therapy/methods , Oncolytic Viruses/genetics , 3-Iodobenzylguanidine/administration & dosage , 3-Iodobenzylguanidine/pharmacokinetics , 3-Iodobenzylguanidine/therapeutic use , Animals , Cell Line, Tumor , Cell Transformation, Neoplastic , Combined Modality Therapy , DNA, Recombinant/genetics , Glioma/metabolism , Glioma/pathology , Humans , Mice , Norepinephrine Plasma Membrane Transport Proteins/genetics , Sequence Deletion , Time Factors
13.
Biol Chem ; 392(8-9): 769-77, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21824004

ABSTRACT

Septin9 (Sept9) is a member of the filament-forming septin family of structural proteins and is associated with a variety of cancers and with hereditary neuralgic amyotrophy. We have generated mice with constitutive and conditional Sept9 knockout alleles. Homozygous deletion of Sept9 results in embryonic lethality around day 10 of gestation whereas mice homozygous for the conditional allele develop normally. Here we report the consequences of homozygous loss of Sept9 in immortalized murine embryonic fibroblasts. Proliferation rate was not changed but cells without Sept9 had an altered morphology compared to normal cells, particularly under low serum stress. Abnormal, fragmented, and multiple nuclei were more frequent in cells without Sept9. Cell migration, as measured by gap-filling and filter-invasion assays, was impaired, but individual cells did not move less than wild-type cells. Sept9 knockout cells showed a reduced resistance to hypo-osmotic stress. Stress fiber and vinculin staining at focal adhesion points was less prominent. Long septin filaments stained for Sept7 disappeared. Instead, staining was found in short, often curved filaments and rings. Furthermore, Sept7 was no longer localized to the mitotic spindle. Together, these data reveal the importance of Sept9 for septin filament formation and general cell stability.


Subject(s)
Septins/metabolism , Animals , Blotting, Western , Cell Movement/genetics , Cell Movement/physiology , Cell Proliferation , Cells, Cultured , Cytoskeleton/genetics , Cytoskeleton/metabolism , Fluorescent Antibody Technique , Mice , Mice, Knockout , Polymerase Chain Reaction , Septins/genetics
14.
Can J Microbiol ; 57(8): 638-50, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21815831

ABSTRACT

ß-Glucosidase activity plays an essential role for efficient and complete hydrolysis of lignocellulosic biomass. Direct use of fungal fermentation broths can be cost saving relative to using commercial enzymes for production of biofuels and bioproducts. Through a fungal screening program for ß-glucosidase activity, strain AP (CBS 127449, Aspergillus saccharolyticus ) showed 10 times greater ß-glucosidase activity than the average of all other fungi screened, with Aspergillus niger showing second greatest activity. The potential of a fermentation broth of strain AP was compared with the commercial ß-glucosidase-containing enzyme preparations Novozym 188 and Cellic CTec. The fermentation broth was found to be a valid substitute for Novozym 188 in cellobiose hydrolysis. The Michaelis-Menten kinetics affinity constant as well as performance in cellobiose hydrolysis with regard to product inhibition were found to be the same for Novozym 188 and the broth of strain AP. Compared with Novozym 188, the fermentation broth had higher specific activity (11.3 U/mg total protein compared with 7.5 U/mg total protein) and also increased thermostability, identified by the thermal activity number of 66.8 vs. 63.4 °C for Novozym 188. The significant thermostability of strain AP ß-glucosidases was further confirmed when compared with Cellic CTec. The ß-glucosidases of strain AP were able to degrade cellodextrins with an exo-acting approach and could hydrolyse pretreated bagasse to monomeric sugars when combined with Celluclast 1.5L. The fungus therefore showed great potential as an onsite producer for ß-glucosidase activity.


Subject(s)
Aspergillus/enzymology , Cellobiose/metabolism , Cellulases/metabolism , Fermentation , Industrial Microbiology , Aspergillus/classification , Aspergillus niger/enzymology , Biomass , Cellulose/analogs & derivatives , Cellulose/metabolism , DNA, Fungal/genetics , DNA, Ribosomal Spacer/genetics , Dextrins/metabolism , Hydrolysis , beta-Glucosidase/metabolism
15.
Appl Biochem Biotechnol ; 164(7): 1058-70, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21360092

ABSTRACT

Cellulosic ethanol production from biomass raw materials involves process steps such as pre-treatment, enzymatic hydrolysis, fermentation, and distillation. Use of streams within cellulosic ethanol production was explored for onsite enzyme production as part of a biorefinery concept. Sixty-four fungal isolates were in plate assays screened for lignocellulolytic activities to discover the most suitable fungal strain with efficient hydrolytic enzymes for lignocellulose conversion. Twenty-five were selected for further enzyme activity studies using a stream derived from the bioethanol process. The filter cake left after hydrolysis and fermentation was chosen as substrate for enzyme production. Five of the 25 isolates were further selected for synergy studies with commercial enzymes, Celluclast 1.5L and Novozym 188. Finally, IBT25747 (Aspergillus niger) and strain AP (CBS 127449, Aspergillus saccharolyticus) were found as promising candidates for onsite enzyme production where the filter cake was inoculated with the respective fungus and in combination with Celluclast 1.5 L used for hydrolysis of pre-treated biomass.


Subject(s)
Aspergillus niger , Biotechnology/methods , Ethanol/metabolism , Lignin/metabolism , beta-Glucosidase/metabolism , Aspergillus niger/enzymology , Aspergillus niger/isolation & purification , Biofuels , Biomass , Cellulase/metabolism , Culture Media , Fermentation , High-Throughput Screening Assays , Hydrolysis , Triticum/metabolism
16.
Int J Syst Evol Microbiol ; 61(Pt 12): 3077-3083, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21335500

ABSTRACT

A novel species, Aspergillus saccharolyticus sp. nov., belonging to the Aspergillus section Nigri group is described. This species was isolated in Denmark from treated hardwood. Its taxonomic status was determined using a polyphasic taxonomic approach including phenotypic (morphology and extrolite profiles) and molecular (ß-tubulin, internal transcribed spacer and calmodulin gene sequences, and universally primed PCR fingerprinting) analysis. Phenotypic and molecular data enabled this novel species to be clearly distinguished from other black aspergilli. A. saccharolyticus is a uniseriate Aspergillus species that is morphologically similar to Aspergillus japonicus and Aspergillus aculeatus, but has a totally different extrolite profile compared to any known Aspergillus species. The type strain of A. saccharolyticus sp. nov. is CBS 127449(T) (=IBT 28509(T)).


Subject(s)
Aspergillus/classification , Aspergillus/isolation & purification , Wood/microbiology , Aspergillus/genetics , DNA, Fungal/genetics , DNA, Ribosomal Spacer/genetics , Denmark , Fungal Proteins/genetics , Molecular Sequence Data , Phylogeny
17.
Leuk Lymphoma ; 50(10): 1647-60, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19701853

ABSTRACT

The aim of the study was to investigate the expression of angio- and lymphangiogenic molecules (vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4) in non-Hodgkin lymphomas (NHL) treated in the pre-rituximab era. Pre-therapeutic lymph-node biopsies from 155 patients with NHL (64 follicular lymphomas (FLs), 47 de novo diffuse large B-cell lymphomas (DLBCL) and 44 peripheral T-cell lymphomas (PTCL)) were stained by in situ hybridization and immunohistochemistry. Tumor cell expression of VEGF, VEGF-C and their receptors was detected in most of the analyzed biopsies. In FL, diffuse intratumoral VEGF staining correlated with shorter overall survival (OS) (p = 0.008) and diffuse KDR staining was associated with a higher risk of histologic transformation (p = 0.05). In DLBCL, high KDR expression predicted poor treatment response (p = 0.03) and had a significant adverse impact on OS (p < 0.001). In PTCL, diffuse tissue distribution of VEGF mRNA correlated with an unfavorable 5-year OS (p = 0.004).


Subject(s)
Lymphoma, Follicular/genetics , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, T-Cell, Peripheral/genetics , Neoplasm Proteins/analysis , Vascular Endothelial Growth Factor A/analysis , Vascular Endothelial Growth Factor C/analysis , Vascular Endothelial Growth Factor Receptor-1/analysis , Vascular Endothelial Growth Factor Receptor-2/analysis , Aged , Cell Nucleus/chemistry , Cytoplasm/chemistry , Female , Gene Expression Profiling , Humans , Lymph Nodes/chemistry , Lymph Nodes/pathology , Lymphoma, Follicular/mortality , Lymphoma, Follicular/pathology , Lymphoma, Large B-Cell, Diffuse/mortality , Lymphoma, Large B-Cell, Diffuse/pathology , Lymphoma, T-Cell, Peripheral/mortality , Lymphoma, T-Cell, Peripheral/pathology , Male , Middle Aged , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neovascularization, Pathologic/etiology , Neovascularization, Pathologic/genetics , Prognosis , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , RNA, Neoplasm/analysis , RNA, Neoplasm/biosynthesis , RNA, Neoplasm/genetics , Retrospective Studies , Vascular Endothelial Growth Factor A/biosynthesis , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor C/biosynthesis , Vascular Endothelial Growth Factor C/genetics , Vascular Endothelial Growth Factor Receptor-1/biosynthesis , Vascular Endothelial Growth Factor Receptor-1/genetics , Vascular Endothelial Growth Factor Receptor-2/biosynthesis , Vascular Endothelial Growth Factor Receptor-2/genetics
18.
J Neurosci Res ; 87(15): 3492-501, 2009 Nov 15.
Article in English | MEDLINE | ID: mdl-19565653

ABSTRACT

Formation of the paranodal axoglial junction (PNJ) requires the presence of three cell adhesion molecules: the 155-kDa isoform of neurofascin (NF155) on the glial membrane and a complex of Caspr and contactin found on the axolemma. Here we report that the clustering of Caspr along myelinated axons during development differs fundamentally between the central (CNS) and peripheral (PNS) nervous systems. In cultures of Schwann cells (SC) and dorsal root ganglion (DRG) neurons, membrane accumulation of Caspr was detected only after myelination. In contrast, in oligodendrocytes (OL)/DRG neurons cocultures, Caspr was clustered upon initial glial cell contact already before myelination had begun. Premyelination clustering of Caspr was detected in cultures of oligodendrocytes and retinal ganglion cells, motor neurons, and DRG neurons as well as in mixed cell cultures of rat forebrain and spinal cords. Cocultures of oligodendrocyte precursor cells isolated from contactin- or neurofascin-deficient mice with wild-type DRG neurons showed that clustering of Caspr at initial contact sites between OL processes and the axon requires glial expression of NF155 but not of contactin. These results demonstrate that the expression of membrane proteins along the axolemma is determined by the type of the contacting glial cells and is not an intrinsic characteristic of the axon.


Subject(s)
Cell Adhesion Molecules, Neuronal/metabolism , Ganglia, Spinal/metabolism , Oligodendroglia/metabolism , Schwann Cells/metabolism , Sensory Receptor Cells/metabolism , Animals , Cell Adhesion Molecules/metabolism , Cell Adhesion Molecules/ultrastructure , Cell Adhesion Molecules, Neuronal/genetics , Cell Communication/physiology , Cells, Cultured , Coculture Techniques , Ganglia, Spinal/cytology , Intercellular Junctions/metabolism , Intercellular Junctions/ultrastructure , Mice , Mice, Inbred ICR , Mice, Knockout , Motor Neurons/metabolism , Motor Neurons/ultrastructure , Myelin Sheath/metabolism , Myelin Sheath/ultrastructure , Nerve Fibers, Myelinated/metabolism , Nerve Fibers, Myelinated/ultrastructure , Nerve Growth Factors/metabolism , Nerve Growth Factors/ultrastructure , Oligodendroglia/cytology , Prosencephalon/metabolism , Prosencephalon/ultrastructure , Ranvier's Nodes/metabolism , Ranvier's Nodes/ultrastructure , Rats , Rats, Wistar , Retinal Ganglion Cells/cytology , Retinal Ganglion Cells/metabolism , Schwann Cells/cytology , Sensory Receptor Cells/cytology , Spinal Cord/metabolism , Spinal Cord/ultrastructure
19.
Gene ; 442(1-2): 55-62, 2009 Aug 01.
Article in English | MEDLINE | ID: mdl-19376211

ABSTRACT

Neurogranin (Nrgn) is a highly expressed brain-specific protein, which sequesters calmodulin at low Ca(2+)-levels. We report here on retroviral activation of the Nrgn gene in tumors induced by the T-cell lymphomagenic SL3-3 murine leukemia virus. We have performed a systematic expression analysis of Nrgn in various mouse tissues and SL3-3 induced T-cell tumors. This demonstrated that insertional activation of Nrgn increased RNA and protein expression levels to that observed in brain. Furthermore, elevated Nrgn expression was also observed in some T-cell tumors with no detected provirus integrations into this genomic region. The presented data demonstrate that Nrgn can be produced at high levels outside the brain, and suggest a novel oncogenic role in T-cell lymphomas in mice.


Subject(s)
Brain/metabolism , Gene Expression Regulation, Leukemic , Leukemia Virus, Murine/genetics , Lymphoma, T-Cell/genetics , Neurogranin/genetics , Transcriptional Activation , Animals , Lymphoma, T-Cell/virology , Mice , Mutagenesis, Insertional , Proviruses/genetics
20.
BMC Mol Biol ; 10: 2, 2009 Jan 21.
Article in English | MEDLINE | ID: mdl-19159451

ABSTRACT

BACKGROUND: The Bach2 gene functions as a transcriptional repressor in B-cells, showing high expression level only before the plasma cell stage. Several lines of evidence indicate that Bach2 is a B-cell specific tumor suppressor. We here address patterns of insertional mutagenesis and expression of Bach2 is a murine retroviral model of B-cell lymphoma induction. RESULTS: We report that the Bach2 gene is a target of proviral integrations in B-cell lymphomas induced by murine leukemia virus. An alternative Bach2 promoter was identified within intron 2 and this promoter was activated in one of the tumors harboring proviral integration. The alternative promoter was active in both normal and tumor tissue and the tissue specificity of the two Bach2 promoters was similar. Three different alternatively used Bach2 terminal exons were identified to be located in intron 4. The inclusion of these exons resulted in the generation of Bach2 mRNA with open reading frames lacking the bZIP DNA binding domain present in the normal Bach2 protein, but retaining a partial BTB protein dimerization domain. Such Bach2 protein was excluded from the cell nucleus. CONCLUSION: We have identified an alternative promoter and new protein isoforms of Bach2. Our data imply that activation of an alternative promoter by proviral integration serves as a possible mechanism of up-regulation of the Bach2 gene with a potential role in B-cell lymphomagenesis. The finding of novel Bach2 transcripts and protein isoforms will facilitate a better insight into the normal and pathophysiological regulation of the Bach2 gene.


Subject(s)
Alternative Splicing , Basic-Leucine Zipper Transcription Factors/genetics , Leukemia Virus, Murine/physiology , Lymphoma, B-Cell/virology , Virus Integration , Animals , Base Sequence , Basic-Leucine Zipper Transcription Factors/metabolism , Cell Line , Genetic Vectors/genetics , Genetic Vectors/metabolism , Humans , Leukemia Virus, Murine/genetics , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/metabolism , Mice , Mice, Inbred Strains , Molecular Sequence Data , Mutagenesis, Insertional , Promoter Regions, Genetic , Protein Isoforms/genetics , Protein Isoforms/metabolism , Transcription, Genetic , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...